In this issue:
Residual disease in the peritoneum following neoadjuvant chemotherapy
Weekly paclitaxel elicits a response in relapsed ovarian sex cord-stromal tumours
CA-125 alone is inadequate to detect progression in BRCA-mutated ovarian cancer
Neoadjuvant dose-dense chemotherapy shows superiority in a Japanese cohort
Appendectomy at the time of ovarian cancer staging increases infectious complications
LION-PAW sub-study finds a negative impact of surgery on sexual function
Does a delay between chemotherapy and interval debulking surgery affect survival?
Increased surgical site infections with concurrent bowel procedures and cytoreductive ovarian surgery
A multimodality triage algorithm may improve cytoreductive outcomes
Superior survival achieved with primary debulking compared to interval debulking surgery
Please login below to download this issue (PDF)